RU2664442C2 - Способ снижения веса - Google Patents

Способ снижения веса Download PDF

Info

Publication number
RU2664442C2
RU2664442C2 RU2014150946A RU2014150946A RU2664442C2 RU 2664442 C2 RU2664442 C2 RU 2664442C2 RU 2014150946 A RU2014150946 A RU 2014150946A RU 2014150946 A RU2014150946 A RU 2014150946A RU 2664442 C2 RU2664442 C2 RU 2664442C2
Authority
RU
Russia
Prior art keywords
metformin
methazolamide
amount
treatment
weight loss
Prior art date
Application number
RU2014150946A
Other languages
English (en)
Russian (ru)
Other versions
RU2014150946A (ru
Inventor
Кен УОЛДЕР
Гай КРИППНЕР
Джофф НИКОЛСОН
Original Assignee
Найя Метаболик, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Найя Метаболик, Инк. filed Critical Найя Метаболик, Инк.
Publication of RU2014150946A publication Critical patent/RU2014150946A/ru
Application granted granted Critical
Publication of RU2664442C2 publication Critical patent/RU2664442C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
RU2014150946A 2012-05-24 2013-03-15 Способ снижения веса RU2664442C2 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261651335P 2012-05-24 2012-05-24
US61/651,335 2012-05-24
AU61/651,335 2012-05-24
PCT/AU2013/000259 WO2013173858A1 (en) 2012-05-24 2013-03-15 A method of weight reduction

Publications (2)

Publication Number Publication Date
RU2014150946A RU2014150946A (ru) 2016-07-10
RU2664442C2 true RU2664442C2 (ru) 2018-08-17

Family

ID=49622926

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014150946A RU2664442C2 (ru) 2012-05-24 2013-03-15 Способ снижения веса

Country Status (16)

Country Link
US (2) US20150174108A1 (enExample)
EP (1) EP2854806A4 (enExample)
JP (1) JP6438389B2 (enExample)
KR (1) KR20150023404A (enExample)
CN (1) CN104582701B (enExample)
AU (1) AU2013202981B2 (enExample)
BR (1) BR112014029302A2 (enExample)
CA (1) CA2874512A1 (enExample)
CO (1) CO7160083A2 (enExample)
HK (1) HK1209041A1 (enExample)
MX (1) MX2014014316A (enExample)
NZ (1) NZ702666A (enExample)
RU (1) RU2664442C2 (enExample)
SG (1) SG11201407786XA (enExample)
WO (1) WO2013173858A1 (enExample)
ZA (1) ZA201408703B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2660170T3 (es) 2007-01-25 2018-03-21 NAIA Metabolic, Inc. Sensibilizadores a la insulina y métodos de tratamiento
BR112014029308A2 (pt) * 2012-05-24 2017-06-27 Verva Pharmaceuticals Ltd um método de melhorar a função hepática
US10039752B2 (en) * 2016-07-21 2018-08-07 Cipla Limited Methazolamide for the treatment of cancer

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008089521A1 (en) * 2007-01-25 2008-07-31 Verva Pharmaceuticals Ltd Insulin sensitisers and methods of treatment
RU2350327C2 (ru) * 2003-04-29 2009-03-27 Ориксиджен Серапьютикс, Инкорпорэйтд Составы, вызывающие потерю веса
RU2356247C2 (ru) * 2003-03-18 2009-05-27 Новартис Аг Комбинации и композиции, содержащие жирные кислоты и аминокислоты, их применение для предупреждения, замедления прогрессирования или лечения диабета и связанных с диабетом заболеваний и состояний, способ снижения веса тела млекопитающего, набор

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2783241A (en) * 1957-02-26 S-acylimino-x-substituted-az-i
JP2000080047A (ja) * 1998-06-30 2000-03-21 Takeda Chem Ind Ltd 医 薬
US6946243B2 (en) * 2000-07-20 2005-09-20 Solvay Pharmaceuticals Gmbh Method of identifying compounds suitable for treatment and/or prophylaxis of obesity
WO2002013800A2 (en) * 2000-08-11 2002-02-21 Einar Stefansson Method for the prevention and treatment of retinopathy
WO2005012243A2 (en) 2003-08-01 2005-02-10 Janssen Pharmaceutica N.V. Substituted indole-o-glucosides
WO2007114948A2 (en) * 2006-04-04 2007-10-11 The Brigham And Women's Hospital, Inc. Methods and compositions for inhibiting cell death
TW201105338A (en) * 2009-07-01 2011-02-16 Kissei Pharmaceutical Medicine derived from a combination of SGLT1-inhibitor and DPP-IV inhibitor
CN103068400A (zh) * 2010-06-25 2013-04-24 阿斯顿大学 具有脂类动员性质的糖蛋白及其治疗用途
JP5722892B2 (ja) * 2010-07-15 2015-05-27 武田薬品工業株式会社 複素環化合物
BR112014029308A2 (pt) * 2012-05-24 2017-06-27 Verva Pharmaceuticals Ltd um método de melhorar a função hepática

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2356247C2 (ru) * 2003-03-18 2009-05-27 Новартис Аг Комбинации и композиции, содержащие жирные кислоты и аминокислоты, их применение для предупреждения, замедления прогрессирования или лечения диабета и связанных с диабетом заболеваний и состояний, способ снижения веса тела млекопитающего, набор
RU2350327C2 (ru) * 2003-04-29 2009-03-27 Ориксиджен Серапьютикс, Инкорпорэйтд Составы, вызывающие потерю веса
WO2008089521A1 (en) * 2007-01-25 2008-07-31 Verva Pharmaceuticals Ltd Insulin sensitisers and methods of treatment

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ЧАЗОВА И.Е. и др. Метаболический синдром. - М.: Медиа Медика, 2004, с.2-6. *

Also Published As

Publication number Publication date
AU2013202981B2 (en) 2014-11-13
CN104582701A (zh) 2015-04-29
CN104582701B (zh) 2018-01-16
BR112014029302A2 (pt) 2017-06-27
EP2854806A1 (en) 2015-04-08
HK1209041A1 (en) 2016-03-24
WO2013173858A1 (en) 2013-11-28
US20150174108A1 (en) 2015-06-25
CO7160083A2 (es) 2015-01-15
CA2874512A1 (en) 2013-11-28
JP2015520759A (ja) 2015-07-23
ZA201408703B (en) 2018-07-25
AU2013202981A1 (en) 2013-12-12
EP2854806A4 (en) 2015-11-18
RU2014150946A (ru) 2016-07-10
JP6438389B2 (ja) 2018-12-12
NZ702666A (en) 2016-08-26
MX2014014316A (es) 2015-07-06
US20180333398A1 (en) 2018-11-22
KR20150023404A (ko) 2015-03-05
SG11201407786XA (en) 2015-03-30

Similar Documents

Publication Publication Date Title
JP6676108B2 (ja) ２型糖尿病の処置のためのリキシセナチド及びメトホルミン
EP3137065A2 (en) Compositions, methods and uses for the treatment of diabetic neuropathies
JP2019089825A (ja) 高尿酸血症の治療におけるカナグリフロジンとプロベネシドの組合せ
EP2714022A1 (en) Combination for treatment of diabetes mellitus
US20180333399A1 (en) Method of improving liver function
US20180333398A1 (en) Method of weight reduction
CA3104916C (en) Pharmaceutical composition for preventing diabetes and use thereof
JP5117230B2 (ja) ２型糖尿病治療用の併用医薬
KR20080028415A (ko) ＰＰＡＲγ 애고니스트를 함유하는 의약 조성물
AU2016206292B2 (en) A method of improving liver function
WO2017126524A1 (ja) 糖尿病治療剤の併用
HK1055674B (en) Drugs for complications of diabetes and neuropathy and utilization thereof

Legal Events

Date Code Title Description
HZ9A Changing address for correspondence with an applicant
MM4A The patent is invalid due to non-payment of fees

Effective date: 20200316